Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
246.79
+2.77 (1.14%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Insulet Revenue
In the year 2024, Insulet had annual revenue of $2.07B with 22.07% growth. Insulet had revenue of $597.50M in the quarter ending December 31, 2024, with 17.20% growth.
Revenue (ttm)
$2.07B
Revenue Growth
+22.07%
P/S Ratio
8.34
Revenue / Employee
$531,179
Employees
3,900
Market Cap
17.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.07B | 374.50M | 22.07% |
Dec 31, 2023 | 1.70B | 391.80M | 30.02% |
Dec 31, 2022 | 1.31B | 206.50M | 18.79% |
Dec 31, 2021 | 1.10B | 194.40M | 21.49% |
Dec 31, 2020 | 904.40M | 166.20M | 22.51% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
PODD News
- 21 days ago - Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025 - Business Wire
- 5 weeks ago - Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections - Business Wire
- 5 weeks ago - Insulet Announces Pricing of Senior Notes Due 2033 - Business Wire
- 5 weeks ago - Insulet Announces Proposed Financing Transactions - Business Wire
- 5 weeks ago - Insulet Leans Bullish (Technical Analysis) - Seeking Alpha
- 6 weeks ago - Insulet to Host Investor Day on June 5, 2025 - Business Wire
- 2 months ago - Insulet Sales Keep Rising - FXEmpire
- 2 months ago - Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst - Benzinga